Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (882)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Figitumumab	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Figitumumab Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Forimtamig	Bispecific T-Cell Engager, GPRC5D x CD3	Hematologic (Multiple Myeloma)
Molecule Forimtamig Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, GPRC5D x CD3
Ganitumab	Investigational Monoclonal / ADC Agent	Solid Tumour
Molecule Ganitumab Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Gartisertib	DNA Damage Response Inhibitor	Solid Tumour
Molecule Gartisertib Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor
Golcadomide	Cereblon E3 Ligase Modulator (CELMoD)	Hematologic (Lymphoma)
Molecule Golcadomide Therapeutic Category Immunomodulatory Agent Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism Cereblon E3 Ligase Modulator (CELMoD)
GTx-024 (Enobosarm)	SARM (Selective Androgen Receptor Modulator)	Solid Tumour
Molecule GTx-024 (Enobosarm) Therapeutic Category Supportive Care (Investigational Cachexia) Oncology Type Solid Tumour Drug Class / Mechanism SARM (Selective Androgen Receptor Modulator)
Guadecitabine	Hypomethylating / Investigational Agent	Hematologic (MDS/AML)
Molecule Guadecitabine Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic (MDS/AML) Drug Class / Mechanism Hypomethylating / Investigational Agent
IACS-010759	Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)	Solid Tumour
Molecule IACS-010759 Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Ianalumab	Targeted Protein Degrader	Hematologic
Molecule Ianalumab Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism Targeted Protein Degrader
IBI322 (CD47/PD-L1)	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule IBI322 (CD47/PD-L1) Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Ifinatamab Deruxtecan	Anti-B7-H3 ADC, Topoisomerase I Inhibitor Payload	Solid Tumour
Molecule Ifinatamab Deruxtecan Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Anti-B7-H3 ADC, Topoisomerase I Inhibitor Payload
Ilorasertib	Polo-Like / Aurora Kinase Inhibitor	Both (Solid & Hematologic)
Molecule Ilorasertib Therapeutic Category Targeted Therapy (Investigational) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Polo-Like / Aurora Kinase Inhibitor

Figitumumab Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Forimtamig Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, GPRC5D x CD3
Ganitumab Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Investigational Monoclonal / ADC Agent
Gartisertib Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor
Golcadomide Immunomodulatory Agent
Therapeutic Category Immunomodulatory Agent Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism Cereblon E3 Ligase Modulator (CELMoD)
GTx-024 (Enobosarm) Supportive Care (Investigational Cachexia)
Therapeutic Category Supportive Care (Investigational Cachexia) Oncology Type Solid Tumour Drug Class / Mechanism SARM (Selective Androgen Receptor Modulator)
Guadecitabine Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic (MDS/AML) Drug Class / Mechanism Hypomethylating / Investigational Agent
IACS-010759 Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Solid Tumour Drug Class / Mechanism Metabolic Pathway Inhibitor (IDO/STAT3/Glutaminase)
Ianalumab Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism Targeted Protein Degrader
IBI322 (CD47/PD-L1) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Ifinatamab Deruxtecan Targeted Therapy (Investigational Antibody / ADC)
Therapeutic Category Targeted Therapy (Investigational Antibody / ADC) Oncology Type Solid Tumour Drug Class / Mechanism Anti-B7-H3 ADC, Topoisomerase I Inhibitor Payload
Ilorasertib Targeted Therapy (Investigational)
Therapeutic Category Targeted Therapy (Investigational) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Polo-Like / Aurora Kinase Inhibitor

‹ 1 … 65 66 67 68 69 … 74 ›

Product Range

Company

Global Network

Products

All Products (882)

Figitumumab

Forimtamig

Ganitumab

Gartisertib

Golcadomide

GTx-024 (Enobosarm)

Guadecitabine

IACS-010759

Ianalumab

IBI322 (CD47/PD-L1)

Ifinatamab Deruxtecan

Ilorasertib

Figitumumab

Forimtamig

Ganitumab

Gartisertib

Golcadomide

GTx-024 (Enobosarm)

Guadecitabine

IACS-010759

Ianalumab

IBI322 (CD47/PD-L1)

Ifinatamab Deruxtecan

Ilorasertib